Latest webfg news

AstraZeneca receives positive Phase III trial results from Enhertu study	22 Apr
London close: Stocks fall as China retaliates to latest US tariffs	09 Apr
AstraZeneca's Enhertu gets further EU approval	04 Apr
London close: Stocks slide in global reaction to Trump tariffs	03 Apr
UK pharma stocks avoid selloff	03 Apr
AstraZeneca makes regulatory progress with Imfinzi, Calquence	31 Mar
AstraZeneca spending $2.5bn on new R&D centre, biotech deals in China	21 Mar
AstraZeneca buys biotech firm Esobiotec for up to $1bn	17 Mar
AstraZeneca hails trial results for imfinzi on gastric cancer	07 Mar
AstraZeneca's Imfinzi gets recommended for fresh EU approval	03 Mar
AstraZeneca's camizestrant shows promise in breast cancer trial	26 Feb
London close: Stocks slip as US jobless claims rise	20 Feb
UBS ups rating on AstraZeneca to 'buy'	13 Feb
Morgan Stanley sees huge upside at AstraZeneca	12 Feb
Revenues, profits surge at AstraZeneca	06 Feb
AstraZeneca's Imfinzi set for go-ahead by EU to treat lung cancer	03 Feb
AstraZeneca's Enhertu gets new US approval	30 Jan
AstraZeneca gets first US approval for cancer treatment Datroway	20 Jan
AstraZeneca's rare cancer drug Calquence gets US regulatory nod	17 Jan
London close: Stocks mixed in quiet post-Christmas trade	27 Dec